Global Refractive Surgery Devices And Equipment Market

The medical lasers market consists of sales of medical lasers and related services by entities (organizations, sole traders, and partnerships) that manufacture medical lasers. Medical lasers are devices that treat or remove tissues using precisely focused light sources. Medical lasers find their applications in several surgical procedures including eye surgery, cosmetic surgery, dental procedures, and other general procedures. The main type of medical lasers is solid-state laser systems, gas laser systems, dye laser systems, and diode laser systems. The solid-state laser system is a laser system that uses a gain medium as a solid instead of liquid as in dye lasers and gas as in gas lasers. The applications involved are surgical, cosmetic, and dental. The end-users involved are ophthalmology, dermatology, gynecology, dentistry, urology, cardiovascular, and other The global medical lasers market size is expected to grow from $4.84 billion in 2021 to $5.56 billion in 2022 at a compound annual growth rate (CAGR) of 14.9%. The global medical laser market size is expected to grow to $9.31 billion in 2026 at a CAGR of 13.7%. The increased demand for minimally invasive procedures contributed to the medical lasers market’s growth during the period. The surge in aesthetic and cosmetic procedures propelled the demand for minimally invasive surgeries worldwide. According to the article published by Beautynews in April 2021, the number of facial plastic surgery procedures in the USA in 2020 is approximately 56,084 and the one was the brow lift procedure is nearly 31,404. Thus, the high usage of medical lasers to perform minimally invasive aesthetic and cosmetic surgeries increases the demand for medical lasers. The high cost of surgeries limits the growth of the medical lasers market. The high cost of treatments involving medical lasers limited the adoption and demand for lasers used to perform minimally invasive surgeries. For instance, the average cost of LASIK surgery performed in the USA was $2,246 per eye in 2019. Therefore, the high and increasing cost of surgeries is likely to act as a restraint to the growth of the medical lasers market. Major players operating in the market are focusing on developing new innovative products with advanced techniques to serve the healthcare professionals and their patients better. For instance, in April 2019, Lumenis Ltd., an energy-based medical device company based in Israel, introduced Legend Pro+, a new skin rejuvenating technology and a unique multi-application platform powered by clinically proven and complementary technologies. Similarly, in July 2019, Ra Medical Systems, a USA-based medical laser company, announced the launch of Pharos, a new dermatology excimer laser for the treatment of psoriasis, atopic dermatitis, and vitiligo. Pharos offers better comfort and visibility of the treatment site and is designed to improve physician and patient experience. In December 2019, Lumibird Group (Quantel Medical), a France-based company that specializes in medical lasers, announced the acquisition of Ellex’s laser and ultrasound business for $69 million. The acquisition is expected to expand Lumibird Group’s product portfolio with Ellex’s laser and ultrasound technologies for the diagnosis and treatment of ocular diseases. Both companies focus on strengthening the portfolio for diagnostic devices including ultrasound and laser products. Ellex is an Australia-based company engaged in manufacturing ophthalmic lasers and ultrasound systems. Major players in the medical lasers market are El.En. S.p.A, Ellex Medical Lasers Ltd, Lumenis, Alcon Laboratories Inc, AngioDynamics Corp, American Medical Systems Inc, Biolase Inc, Bausch & Lomb Holdings, Cardiogenesis Corporation Inc, and Boston Scientific. North America was the largest region in the medical lasers market in 2021. Asia Pacific was the second largest region in the global medical lasers market during the forecast period. The regions covered in the global medical laser market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical lasers market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global medical lasers market is segmented - 1) By Product Type: Solid State Laser Systems, Gas Laser Systems, Dye Laser Systems, Diode Laser Systems 2) By Application: Surgical, Cosmetic, Dental 3) By End-Use: Ophthalmology, Dermatology, Gynecology, Dentistry, Urology, Cardiovascular, Others

The cardiovascular medical lasers market consists of the sale of cardiovascular medical lasers and related services by entities that manufacture them. Cardiovascular medical lasers are used in the treatment of heart-related medical conditions especially for clearing heart blockages. The cardiovascular medical lasers market covered in this report is segmented by type into excimer laser and carbon dioxide laser. The carbon dioxide laser helps in removing thin layers of skin with minimal damage to the surrounding structures. These are used in various applications such as laser vascular anastomosis, transmyocardial laser revascularization, and laser angioplasty for peripheral arterial diseases that are used by end users such as hospitals, specialty clinics, and ambulatory surgery centers. The global cardiovascular medical lasers market size is expected to grow from $0.10 billion in 2021 to $0.15 billion in 2022 at a compound annual growth rate (CAGR) of 44.3%. The global cardiovascular medical laser market is expected to grow to $0.66 billion in 2026 at a CAGR of 45.6%. The rising prevalence of cardiovascular diseases is expected to drive the cardiovascular medical laser market. The increased prevalence of cardiovascular diseases can be attributed to the increase in the use of smoking, physical inactivity, and an unhealthy diet. For instance, according to the World Health Organization, in 2019, 17.9 million people died from cardiovascular diseases worldwide. According to the British Heart Foundation, coronary heart disease is responsible for around 64,000 deaths in the UK each year, an average of 180 people each day, or one death around every eight minutes. One in seven men and one in 12 women in the UK die from coronary heart disease. Therefore, the increasing prevalence of cardiovascular diseases is expected to drive the growth of cardiovascular medical lasers. Alternative treatment methods for cardiovascular ailments are increasingly becoming popular globally and this is expected to have a negative impact on the revenues of the cardiovascular medical laser market. Treatments of heart diseases using medical procedures such as coronary angioplasty, stent implantation, thrombolytic therapy, coronary artery bypass graft surgery (CABG), artificial pacemaker surgery, defibrillation, and heart valve surgery are more commonly used for the treatment of heart disease compared to the treatments employing lasers. According iData Research, around 340,000 CABG procedures are performed per year in the United States. This trend is expected to continue during the forecast period and limit the demand for cardiovascular medical lasers. Cardiovascular medical laser manufacturers are constantly investing in technologies for faster diagnosis and efficient treatment of heart conditions. Areas of technological advances include new wavelengths, more rugged setups, lower-cost systems, and other advancements are being combined with minimally invasive techniques. FDA cleared Ra Medical’s vascular products including cardiovascular lasers that can be used to treat peripheral arteries and veins. The laser works at 308-nanometer wavelength, which breaks chemical bonds and decomposes the blockage into its part, thereby reducing the risk for the patient. In October 2019, AngioDynamics Inc., a US-based medical device company, acquired Eximo Medical for $66million. This acquisition extends the current product line of AngioDynamics vascular treatments and therapies by incorporating the patented 355nm laser atherectomy system from Eximo, which has earned 510(k) approval for use in the treatment of peripheral artery disease. Eximo Medical is an Israeli medical device company that offers minimally invasive medical devices used for cardiovascular diseases and oncology. Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. North America was the largest region in the cardiovascular medical lasers market in 2021. Asia Pacific was the second largest region in the global cardiovascular medical lasers market during the forecast period. The regions covered in the global cardiovascular medical laser market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cardiovascular medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The global cardiovascular medical lasers market is segmented - 1) By Type: Excimer Laser, Carbon Dioxide Laser 2) By Application: Laser Vascular Anastomosis, Transmyocardial Laser Revascularization, Laser Angioplasty for Peripheral Arterial Diseases 3) By End-Use: Hospitals, Specialty Clinics, Ambulatory Surgery Centers

The ophthalmic medical lasers market consists of sales of ophthalmic medical lasers and related services by companies that manufacture them. Ophthalmic medical lasers are used for the pain-free treatment of diseases related to the eyes. The main products of the ophthalmic medical lasers are diode lasers, femtosecond lasers, excimer lasers aromatherapy, ND:YAG lasers, and others. A diode laser is a semiconductor that uses a p-n junction for producing coherent radiation with the same frequency and phase which is either in the visible or infrared spectrum. The various applications include refractive error correction, cataract removal, diabetic retinopathy, glaucoma, age-related macular degeneration, and others. The various end-users are hospitals, specialty clinics, and ambulatory surgery centers. The global ophthalmic medical lasers market size is expected to grow from $1.04 billion in 2021 to $1.12 billion in 2022 at a compound annual growth rate (CAGR) of 7.6%. The global ophthalmic medical laser market is expected to grow to $1.46 billion in 2026 at a CAGR of 6.8%. The rising incidence of ocular disorders is driving the demand for the ophthalmic medical lasers market. Ocular disorders are the ones that affect vision and eye health in patients of all ages and treatment with lasers helps reshape the eye cornea for better focus, which contributes to an improved vision. According to a publication by the World Health Organization (WHO) in October 2019, 1 billion people have lost the vision that could have been kept in check, including those with mild to extreme distance vision deficiency to blindness due to untreated refractive error (123.7 million), cataract (65.2 million), glaucoma (6.9 million), corneal distortion (4.2 million), diabetic retinopathy (3 million), and trachoma (2 million) as well as close vision loss (826 million) induced by unaddressed presbyopia. The rise in the incidence of ocular disease that requires laser treatment contributes to the growth of the ophthalmic medical lasers market. The availability of alternative therapies for vision correction is expected to hinder the ophthalmic medical lasers market. The alternatives for lasers in ophthalmology include using a lens for correcting the vision using techniques such as Phakic Intraocular Lens Implants, and Refractive Lens Exchange Surgery. According to the statistics by the American Society of Cataract and Refractive Surgery (ASCRS), 95% of patients who choose to have a standard IOL procedure, which is considered safe for cataract surgery, experience fully restored vision. Therefore, the availability of alternative therapies to correct vision is expected to hamper the ophthalmic medical lasers market. Companies are investing in manufacturing devices that incorporate next-generation technology to treat ocular diseases. Following the trend, in October 2019, Norlase had entered the ophthalmic market with a new single spot laser called LEAF, which is an ultra-compact green laser photocoagulator. In Feb 2020, IRIDEX Corporation, an innovative ophthalmic laser-based medical products provider for the treatment of glaucoma and retinal diseases has launched the second generation of the MicroPulse P3® Device that gives greater stability, visualization, coupling, and fit. In June 2020, Lumibird, a leading France-based laser technologies specialist acquired all of Ellex's laser and ultrasound activities for $70 million. Through this acquisition, the Lumibird group aimed to strengthen its current product portfolio with complimentary high-quality products, and extend its geographical presence, particularly in the US and Japan, as the acquisition included Ellex’s R&D and production site in Adelaide and the commercial subsidiaries based in Australia, Japan, the US, France, and Germany. Ellex is a leading Australia-based ophthalmic equipment manufacturer. Major players in the ophthalmic medical lasers market are Alcon Laboratories Inc, Abbott Medical Optics Inc, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, NIDEK Co Ltd, Lumenis Ltd, and Johnson & Johnson. North America was the largest region in the ophthalmic medical lasers market in 2021. Asia Pacific was the second largest region in the global ophthalmic medical lasers market. The regions covered in the global ophthalmic medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic medical lasers market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The global ophthalmic medical lasers market is segmented - 1) By Product: Diode Lasers, Femtosecond Lasers, Excimer Lasers Aromatherapy, ND:Yag Lasers, Others 2) By End-User: Hospitals, Specialty Clinics and Ambulatory Surgery Centres 3) By Application: Refractive Error Correction, Cataract Removal, Diabetic Retinopathy, Glaucoma, Age-Related Macular Degeneration, Others

The cataract surgery devices and equipment market consist of sales of cataract surgery devices and equipment and related services. Cataract surgery devices and equipment include instruments used for performing cataract surgeries such as small incision cataract surgery and extracapsular surgery in the treatment of cataracts, a condition in which the lens of the eye becomes progressively opaque, resulting in blurred vision. The main types of cataract surgery devices and equipment are intraocular lens (IOL), ophthalmic viscoelastic device (OVD), phacoemulsification equipment, and femtosecond laser equipment. An ophthalmic viscoelastic device is used for performing cataract surgeries. The cataract surgery devices and equipment are used for various surgery types such as extracapsular cataract extraction, phacoemulsification, femtosecond laser, and others. These are used by end-users such as ophthalmology centers, hospitals, and clinics. The global cataract surgery devices and equipment market size is expected to grow from $5.95 billion in 2021 to $6.58 billion in 2022 at a compound annual growth rate (CAGR) of 10.6%. The global cataract surgery devices market size is expected to grow to $9.13 billion in 2026 at a CAGR of 8.5%. The major growth driver for this industry has been the global aging population. In 2019, there were 703 million persons aged 65 years or over in the global population. This number is projected to double to 1.5 billion in 2050. The cases of cataracts in the geriatric population are also expected to increase in the same proportion. According to World Health Organization, the number of cataract cases is expected to increase by 78% by 2050 in the U.S. alone. This presents a huge market for cataract surgery equipment manufacturers shortly by expanding the customer base due to the fast-growing geriatric population. For instance, the population of China is getting older faster than anywhere else in the world, this presents a huge market for the cataract surgery device manufacturers in China. The major challenge that is faced by this industry is the low level of awareness about eye disorders, especially cataracts. Many people do not have proper knowledge about the symptoms of cataracts and do not get the treatment done. This leads to potential revenue loss for the cataract surgery device manufacturers because of the low number of end-users. For example, as per a study done by NCBI, out of 1552 respondents, 89.9% had heard of cataracts but only 42% were aware of any symptom of cataracts, low awareness of cataract symptoms acts as a major restraint for the cataract surgery equipment industry. The cataract surgery devices and equipment industry has witnessed many positive changes introduced by the market players, the most prominent one being the introduction of laser technology. Laser-assisted cataract surgery is used to gather information about the lens, to make the corneal incision, and for the opening in the lens capsule. The advent of laser technology has caused a significant impact on this industry by bringing in new levels of safety and accuracy and advancing cataract surgery. Femtosecond laser platforms have significantly contributed to the precision of cataract surgeries being performed and may soon surpass the traditional hand-held surgeries. For example, Abbott laboratories which lacked this technology, acquired Optimedica for $250 million to enter the laser cataract surgery devices market after witnessing the huge demand and benefits of laser technology. The ophthalmology and medical equipment industry are subject to numerous stringent regulations and the cataract surgery device equipment manufacturers are no exception. These manufacturers need to comply with several regulations of which the European Medical Device Directives and the U.S. Health Care Compliance is the most prominent one. The European Medical Device Directive requires a manufacturer to meet the harmonized standards for placing their devices in the European market. Similarly the U.S. Health Care Compliance has laid down certain guidelines related to standards of business conduct to be followed by the Pharmaceutical manufacturers. The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates the safety of medical devices in the UK, has issued an urgent notice to Carl Zeiss Meditec, for voluntarily recalling a small batch of its intraocular lenses (IOL). The recall was initiated after the manufacturer detected mislabelling of its IOL, Aaren Scientific EC-3 hydrophobic lens with the wrong dioptric power. Therefore, the manufacturers need to comply strictly with the correct labeling of dioptric power on the IOLs. In March 2019, Alcon, a company manufacturing cataract surgery devices acquired PowerVision for a deal amount of $285 million. This acquisition, will implement the growth of the advanced technologies of intraocular lenses and also help the patients with their needs regarding cataract surgery. Power vision, a US-based company, is a medical device company operating in cataract surgical devices. Major players in the cataract surgery devices and equipment market are Alcon Inc., Abbott Laboratories, Carl Zeiss Meditech AG, Essilor International S.A., Opcon Corporation, Allergan, Inc., Bausch & Lomb, Inc., NIDEK Co. Ltd., STAAR Surgical Company, and Johnson & Johnson. North America was the largest region in the cataract surgery devices and equipment market in 2021. Asia Pacific was the second-largest region in the global cataract surgery market. The regions covered in the global cataract surgery equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cataract surgery devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The global cataract surgery devices and equipment market is segmented - 1) By Type: Intraocular Lens (IOL), Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment, Femtosecond Laser Equipment 2) By Application: Ophthalmology Centers, Hospitals, Clinics 3) By Surgery Type: Extracapsular Cataract Extraction, Phacoemulsification, Femtosecond Laser, Others

The cosmetic lasers market consists of sales of cosmetic lasers by entities (organizations, sole traders, and partnerships) that manufacture cosmetic lasers used during cosmetic surgeries. A cosmetic laser is a device used to reduce facial wrinkles and skin irregularities, such as acne scars or blemishes. Cosmetic lasers are also used for removing unwanted hair from the body by beaming highly concentrated light into the hair follicles. It is used to treat In medical conditions, it is used to treat such as sagging eyelid skin, aging skin problems, wrinkles on the face birthmarks, fine lines, and dark circles. The main types of cosmetic lasers are standalone lasers, multiplatform lasers, and the models include pulsed dye laser (PDL), yttrium aluminum garnet (YAG) laser, carbon dioxide laser, erbium, intense pulsed light (IPL), radiofrequency, infrared, others. Standalone lasers have a single wavelength and a small variety of applicators used for treating a narrow range of indications. The multiplatform lasers use a handpiece with a small laser rod positioned inside having different wavelengths for a range of indications. The cosmetic laser is used by hospitals, skincare clinics, cosmetics surgical centers and is applied in various areas including hair removal, skin resurfacing, vascular lesions, scar and acne removal, body contouring, others. The global cosmetic lasers market size is expected to grow from $2.02 billion in 2021 to $2.41 billion in 2022 at a compound annual growth rate (CAGR) of 19.1%. The global cosmetic laser market is expected to grow to $4.95 billion in 2026 at a CAGR of 19.7%. Rising medical tourism supported the growth of the cosmetic lasers market over the historic period. The wide availability of better quality and low costs treatment options is increasing demand for medical tourism which provides better facilities and experienced doctors for better treatment and care, at an economical price. The rise in medical tourism, especially cosmetic surgery medical tourism is likely to escalate the demand for cosmetic lasers. For instance, according to foreign tourist arrivals (FTAs) in India, the medical visas recorded in 2019 were 2,33,918. Medical visitors come to the country for its top-line cancer treatment centers and expertise in cosmetic surgery. Therefore, the upraising medical tourism industry is predicted to augment the demand for cosmetic lasers. The stringent regulations for cosmetic laser products for approval and marketing could be expected to be a restraint for the market in the forecast period. The laser device manufacturers have to comply with several regulations relating to radiation safety, device efficiency and performance, and other FDA guidelines on major hazard classes. The stringent regulatory processes and standards for cosmetic lasers delay the time required for the device to get to the market which could act as a restraint in the forecast period. The companies are increasingly focusing on developing innovative and technologically advanced products to meet the requirement of end-users, expand the company product portfolio, and maximize company sales. For instance, in January 2020, Lumenis, an Israel-based manufacturer of minimally-invasive clinical solutions for aesthetic, surgical, and ophthalmology markets launched LightSheer Quattro, a product that offers hair removal treatment for all skin types. In 2019, India-based medical and aesthetic solutions company, Alma Medical launched a novel device for hair removal named Saprano Titanium, which is quicker, painless, and covers a greater area using multiple wavelengths. In December 2019, US-based private equity company, Potomac Equity Partners, through its portfolio company, Laser MD Medspa, acquired Laser Gentle Medspa for an undisclosed amount. Through this acquisition, Laser MD Medspa expands its geographical presence and gains access to a full suite of cosmetic and aesthetic treatments, including laser hair removal services. Laser Gentle Medspa is a US-based company specializing in laser hair removal, skin rejuvenation, body contouring, and others. Major players in the cosmetic lasers market are Cutera Inc, Cynosure Inc, Lumenis, Aerolase Corporation, ALMA LASERS LTD, Sciton Inc, Syneron Candela, Solta Medical International Inc, ElEn SpA, Lynton Lasers Ltd, and Medicure Group Of Companies. The regions covered in the global cosmetic lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cosmetic laser market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global cosmetic lasers market is segmented - 1) By Type: Standalone Lasers, Multiplatform Lasers 2) By Modality: Pulsed Dye Laser (PDL), YAG Laser, Carbon Dioxide Laser, Erbium, Intense Pulsed Light (IPL), Radiofrequency, Infrared, Others 3) By Application: Hair Removal, Skin Resurfacing, Vascular Lesions, Scar and Acne Removal , Body Contouring, Others 4) By End-User: Hospitals, Skin care clinics, Cosmetics Surgical Centre

The gynecology medical lasers market consists of sales of gynecology medical lasers and related services by entities (organizations, sole traders, and partnerships) that manufacture gynecology medical lasers. Gynecology medical lasers are used in the treatment of diseases in the female reproductive system. Only goods and services traded between entities or sold to end consumers are included. The gynecology medical lasers market covered in this report is segmented by product type into CO2 laser, KTP–argon laser, and Nd:YAG laser. CO2 laser helps in removing thin layers of skin with minimal damage to the surrounding structures. The various applications involved are colposcopy, laparoscopy, and hysteroscopy that are used by end-users such as hospitals, specialized clinics, ambulatory surgical centers, and medical centers. The global gynecology medical lasers market size is expected to grow from $0.15 billion in 2021 to $0.22 billion in 2022 at a compound annual growth rate (CAGR) of 42.8%. The global gynecology medical laser market is expected to grow to $0.93 billion in 2026 at a CAGR of 43.9%. Rising obesity is expected to drive the gynecology medical lasers market. Overweight women have a higher incidence of gynecology disorders. Overweight and obese women are at high risk of reproductive health-related issues. They have a higher risk of infertility, conception rates, miscarriage rates, and increased risk for pregnancy complications. They have poor reproductive outcomes in natural as well as assisted conception. Increasing obesity in women across the globe is driving the demand for gynecology treatment, hence driving the gynecology medical lasers market. The high costs associated with gynecology lasers are a major issue faced by patients across the globe, especially in developing countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. Carbon dioxide laser is the system most commonly used in gynecology and the main indications are a disease of the uterine cervix, vagina, vulva, or perineum. The only disadvantage is their high cost. For instance, CO2 laser therapy costs more than $500 per treatment, with three treatments required initially, followed by annual treatments. Therefore, the high cost of gynecology laser treatment and the lack of skilled technicians in developing countries hamper the demand for such lasers and impact market growth. Gynecology medical laser manufacturers are constantly investing in technologies for faster diagnosis and efficient treatment of gynecological conditions. Areas of technological advances include new wavelengths, more rugged setups, lower-cost systems, and other advancements are being combined with minimally invasive techniques. For instance, FDA cleared the use of the Dynamis PRO laser system for treatments in gynecology and genitourology, which uses two complementary wavelengths, for fast and precise treatments. Major players in the gynecology medical lasers market are Quanta System S.p.A, Cynosure, biolitec AG, Boston Scientific Corporation, DEKA Medical, Limmer Laser, Linline Medical Systems, Fotona, GIGAA Laser, and LISA laser products. North America was the largest region in the gynecology medical lasers market in 2021. Asia Pacific was the second largest region in the global gynecology medical lasers market during the forecast period. The regions covered in the global gynecology medical laser market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the gynecology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The global gynecology medical lasers market is segmented - 1) By Product Type: CO2 Laser, KTP–Argon Laser, Nd:YAG Laser 2) By Application: Colposcopy, Laparoscopy, Hysteroscopy 3) By End-User: Hospital, Specialized Clinics, Ambulatory Surgical Centers, Medical Centers

The laser marking market consists of the sales of laser marker machines by entities (organizations, partnerships, and sole proprietors) that utilize a concentrated beam of light to leave a permanent mark on a surface. A fiber, pulsed, continuous wave, green, or UV laser system is commonly used for laser marking, and it covers a wide range of applications. Laser marking employs no consumables and requires less maintenance than other non-permanent marking procedures like printing or labelling. The main types of laser marking machines includes Co2 laser, fiber laser, green laser, UV laser and YAG laser. The CO2 laser marking machines consist of the sales of laser marking machines by entities (organizations, partnerships, and sole proprietors) that are used for working with non-metallic materials and most plastics. They are the most extensively utilized laser type because of their excellent beam quality. When compared to a Fiber Laser marking machine, CO2 laser marking devices leave a low-intensity mark. The fiber laser marking machines market consists of the sales of a fiber laser by entities (organizations, partnerships, and sole proprietors) that are used because of their versatility, low maintenance, and near-zero consumable requirements. Fiber laser marking machines are developed for high-speed marking applications and are common in industries such as beverage, pharmaceuticals, and extrusion. The green laser marking machines market consists of the sales of the green lasers by entities that are used for micro marking, reflecting material marking, and sensitive plastic marking. The green laser marker is intended for intricate and cool markings on non-reactive materials. The UV laser marking machines market consists of the sales of UV laser machines by entities that are used to label small, sensitive components with less waste, such as circuit boards and silicon wafers. The YAG laser marking machines market consists of the sales of YAG laser machines by entities that are used for etching, marking, and engraving, as well as cutting and welding steel. Micromarketing, deep engraving, annealing, and ablation procedures are all possible with these lasers, making them a versatile tool. The main offerings of laser marking machines includes hardware, software, and services. The main applications of laser marking machines includes automotive, aerospace, machine tool, electronics and microelectronics, medical, packaging, military, and other industries. The global laser marking machine market size is expected to grow from $2.43 billion in 2021 to $2.60 billion in 2022 at a compound annual growth rate (CAGR) of 7.04%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global laser marking market is expected to reach $3.43 billion in 2026 at a CAGR of 7.10%. Increasing adoption of laser marking across end-users is significantly driving the growth of the laser marking machines market. The laser marking is highly adopted for its superior consistency, competitor advantage, precision, and timely engraving. In June 2020, Laserax, a Canada-based industrial laser machines and systems manufacturer, announced the LXQ Fiber Laser Marker series that is redefining how simple and accessible laser system integration can be. The laser's characteristics are intended not just to reduce integration time and expense, but also to facilitate collaboration between system integrators and laser experts, a critical aspect for quick and easy laser integration. This series provides unrivalled speed and reliability, making it suitable for end-users metal marking applications. It is capable of producing permanent marks such as data matrix codes, QR codes, serial numbers, alphanumeric characters, and logos. Hence, the increasing adoption of laser marking across end-users is expected to drive the laser marking market in the upcoming years. Product innovation is a key trend gaining momentum of popularity in the maser marking market. The key players in the laser marking market are focusing on innovating laser marking products to gain their market position. For instance, in November 2019, Coherent, a US-based producer of lasers and photonics technology, has introduced a new Coherent HighLightTM FL-ARM with Fiber-Fiber-Switch, which contains a switchable adjustable ring mode (ARM) fiber laser that can power two different processes or workstations in a sequential manner. Dual fiber output increases productivity in cost-sensitive, high-volume welding applications, such as welding of doors, hang-on parts, ultra-high-strength steel components, and aluminium body frames, particularly in automotive manufacturing. Alternatively, the second fiber might serve as a redundant backup for the first, reducing service downtime. In August 2020, Markem-Imaje, a Switzerland-based product identification & traceability solutions provider has acquired Solaris Laser S.A. for an undisclosed amount. This acquisition reinforces the company's Markem-Imaje's position in the market. Further, this will allow Markem-Image to better meet expanding client demand for laser coding technologies, which provide key reliability and productivity benefits in specific applications. Solaris Laser is a Poland-based company involved in the manufacturing of industrial Fiber and CO2 laser coding, marking, and engraving systems. Major players in the laser marking machine market are Gravotech Marking, Epilog, TYKMA Electrox, Han's Laser, LaserStar Technologies Corporation, Trotec Laser, Mecco, Telesis Technologies, Videojet Technologies, Coherent, Sea Force, Keyence Corporation, Huagong Tech Company, ROFIN-SINAR Laser GmbH, and Universal Laser Systems. Asia Pacific was the largest region in the laser marking machine market in 2021. The regions covered in the global laser marking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the laser marking machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global laser marking machine market is segmented - 1) By Offering: Hardware, Software, Services 2) By Type: CO2 Laser, Fiber Laser, Green Laser, UV Laser, YAG Laser, Others 3) By Application: Automotive, Aerospace, Machine Tool, Electronics and Microelectronics, Medical, Packaging, Military, Others

The ophthalmic devices market consists of sales of ophthalmic devices and related services by entities (organizations, sole traders, and partnerships) that produce ophthalmic devices used in the diagnosis and treatment of eye-related diseases. The main types of ophthalmic devices are vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment are devices that emit ultrasound waves that soften and break up the lens so that it can be removed by suction. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end uses involved are hospitals and clinics, diagnostic laboratories, and others. The global ophthalmic devices market size is expected to grow from $32.8 billion in 2021 to $36.22 billion in 2022 at a compound annual growth rate (CAGR) of 10.4%. The global ophthalmic device market size is then expected to grow to $50.7 billion in 2026 at a CAGR of 8.8%. The femtosecond laser is increasingly being used in cataract surgeries as it provides greater precision than traditional surgical methods. A femtosecond laser emits optical pulses with a duration of below 1 ps (ultrashort pulses), i.e., in the domain of femtoseconds (1 fs = 10-15 s). The medical procedure using this laser is done under computer-guided OCT imaging, hence there is higher control and reliability of the incisions concerning size, shape, and location, than conventional procedures. This process also reduces the risk associated with a human error during the surgery and has a shorter recovery period. Major companies manufacturing femtosecond laser ophthalmic equipment are Myalcon and Precision Lens. Robotic-assisted eye surgeries are being widely used by healthcare services organizations to improve treatment outcomes. Robot-assisted surgeries allow surgeons to perform complex eye operations with improved precision, the amplified scale of motion, reduced tremor, task automation, and flexibility. For instance, the mechatronics and control laboratory and the Jules stein eye institute together developed an intraocular robotic interventional and surgical system (IRISS) which is capable of performing both anterior and posterior intraocular surgery. This system consists of master surgical manipulators to manipulate two surgical instruments simultaneously through tiny ocular incisions and microscope-mounted cameras for 3-D teleoperated surgical visualization. Preceyes BV also developed PRECEYES Surgical System to perform robot-assisted operations inside the eye. Major companies in the ophthalmic devices market include Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health, Companies Inc., Carl Zeiss AG, Flex Ltd, Nidek Co. Ltd., Topcon Corporation, and Rostec State Corporation. North America was the largest region in the global ophthalmic devices market in 2021. Asia Pacific was the second largest region in the global ophthalmic devices market. Africa was the smallest region in the global ophthalmic devices market. The regions covered in the global ophthalmic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The global ophthalmic devices market is segmented - 1) By Type: Vision Care Devices and Equipment, Cataract Surgery Devices and Equipment, Refractive Surgery Devices and Equipment, Diagnostic and Monitoring Ophthalmic Devices and Equipment 2) By End-User: Hospitals and Clinics, Diagnostic Laboratories, Others 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables